Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q2 FY23
Investor Presentation
Q2 FY23
Investor Presentation
Q4 FY22
Investor Presentation
Q4 FY22
Investor Presentation
Q4 FY22
Investor Presentation
Q4 FY22
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Bearish
4
Neutral
8
Bullish
2
Bearish
27
Neutral
8
Bullish
11
Bearish
23
Neutral
0
Bullish
9

Market Cap
₹ 172 Cr
P/E
13.96
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs
172 Cr
Low Risk
14.0
58.5
0.8
1.2
225.80
126.00
Sales CAGR
1Y
1.86%
3Y
15.79%
5Y
16.24%
10Y
11.14%
Profit CAGR
1Y
-2.27%
3Y
18.18%
5Y
21.13%
10Y
18.30%
ROE
TTM
8.89%
3Y
11.82%
5Y
12.52%
10Y
12.88%
ROCE
TTM
11.28%
3Y
15.71%
5Y
16.74%
10Y
17.61%
Performance
UNDER PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 3.10 L in last 5 Years